Massachusetts Financial Services
RXRX icon

Massachusetts Financial Services’s Recursion Pharmaceuticals RXRX Stock Holding History

Massachusetts Financial Services’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-950,594
Closed -$10.1M – 879
2022
Q3 		$10.1M Sell
950,594
-376,499
-28% -$3.81M ﹤0.01% 614
2022
Q2 		$10.8M Sell
1,327,093
-9,657
-0.7% -$64.6K ﹤0.01% 603
2022
Q1 		$9.57M Buy
1,336,750
+36,709
+3% +$390K ﹤0.01% 639
2021
Q4 		$22.3M Buy
1,300,041
+404,181
+45% +$7.6M 0.01% 594
2021
Q3 		$20.6M Sell
895,860
-80,069
-8% -$2.27M 0.01% 612
2021
Q2 		$35.6M Buy
+975,929
New +$28.9M 0.01% 554

Other funds holding RXRX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
DCI
Data Collective IV Palo Alto, California $55.9M AUM 49.14% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services's RXRX Position: Q4 2022 in Review

Massachusetts Financial Services sold out of Recursion Pharmaceuticals (RXRX) in Q4 2022, closing a stake of 950,594 shares — an estimated $10.1M sold.

Massachusetts Financial Services first reported a position in RXRX in Q2 2021 and held it in 6 quarters. The position peaked at $35.6M in Q2 2021. 144 funds tracked by Wall St. Rank hold RXRX as of Q4 2022.

  • Massachusetts Financial Services reported no remaining Recursion Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Massachusetts Financial Services sold 950,594 Recursion Pharmaceuticals shares in Q4 2022, an estimated $10.1M.
  • Massachusetts Financial Services first reported a position in Recursion Pharmaceuticals in Q2 2021 and held it in 6 quarters.
  • Massachusetts Financial Services's Recursion Pharmaceuticals position peaked at $35.6M in Q2 2021.
  • 144 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q4 2022.

Based on Massachusetts Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.